Cargando…
AB007. Protein therapy to regenerate erectile tissue for future management of erectile dysfunction
Oral phosphodiesterase type 5 inhibitor, including sildenafil citrate, are well utilized as first-line therapy because those are effective and convenient for the majority of erectile dysfunction (ED) patients. However, there is a need for increased treatment efficacy for patients with ED. These oral...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186680/ http://dx.doi.org/10.21037/tau.2018.AB007 |